Literature DB >> 16247215

Low-renin (volume dependent) mild-hypertensive patients have impaired flow-mediated and glyceryl-trinitrate stimulated vascular reactivity.

Juan Carlos Yugar-Toledo1, Lúcia Helena Bonalume Tácito, Sílvia Elaine Ferreira-Melo, Walnéia Sousa, Fernanda Consolin-Colombo, Maria Cláudia Irigoyen, Kléber Franchini, Otávio Rizzi Coelho, Heitor Moreno.   

Abstract

BACKGROUND: Low-renin (volume-dependent) hypertension represents 25-30% of all cases of primary hypertension. Endothelial dysfunction and vascular remodeling are associated with hypertension but their relevance to volume-dependent hypertension (VDH) is not yet known. To evaluate this, flow-mediated dilation (FMD) of the brachial artery and the carotid intima-media thickness in the distal common carotid artery were measured and compared between renin-dependent mild-hypertensive patients (RDH) and controls. METHOD AND
RESULTS: The study group comprised 40 mild-hypertensive patients and 25 controls. Plasma renin activity (PRA), plasma aldosterone concentration, angiotensin II and nitrite/nitrate plasma levels were measured. According to PRA, subjects were classified as VDH (<0.6 ng . ml (-1) . h(-1)), or RDH (>0.6 ng . ml(-1) . h (-1)). Vascular function was evaluated by FMD before and after reactive hyperemia (RH) and glyceryl-trinitrate (GTN) administration. FMD in response to RH and GTN in the VDH group when compared with RDH group was 10.2+/-2.8% vs 13.3+/-3.6% (p=0.01); and 16.0+/-3.5% vs 19.9+/-4.5% (p=0.01), respectively.
CONCLUSION: This study showed impaired FMD and reduced GTN response in mildly hypertensive patients with low-renin plasma levels.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16247215     DOI: 10.1253/circj.69.1380

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

Review 1.  Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.

Authors:  Satoshi Morimoto; Atsuhiro Ichihara
Journal:  Hypertens Res       Date:  2020-05-18       Impact factor: 3.872

2.  Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.

Authors:  Scott L Hummel; E Mitchell Seymour; Robert D Brook; Theodore J Kolias; Samar S Sheth; Hannah R Rosenblum; Joanna M Wells; Alan B Weder
Journal:  Hypertension       Date:  2012-10-01       Impact factor: 10.190

3.  Vascular endothelial functions, carotid intima-media thickness, and soluble CD40 ligand levels in dipper and nondipper essential hypertensive patients.

Authors:  Emin Alioglu; Ugur O Turk; Firat Bicak; Istemihan Tengiz; Dincer Atila; Vatan Barisik; Ertugrul Ercan; Mustafa Akin
Journal:  Clin Res Cardiol       Date:  2008-03-17       Impact factor: 5.460

4.  Association of serum angiopoietin-like protein 2 with carotid intima-media thickness in subjects with type 2 diabetes.

Authors:  Chang Hee Jung; Woo Je Lee; Min Jung Lee; Yu Mi Kang; Jung Eun Jang; Jaechan Leem; Yoo La Lee; So Mi Seol; Hae Kyeong Yoon; Joong-Yeol Park
Journal:  Cardiovasc Diabetol       Date:  2015-04-15       Impact factor: 9.951

Review 5.  Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists.

Authors:  Juan Carlos Yugar-Toledo; Rodrigo Modolo; Ana Paula de Faria; Heitor Moreno
Journal:  Vasc Health Risk Manag       Date:  2017-10-16

6.  Endothelial Vascular Function in Hypertensive Patients After Renin-Angiotensin System Blockad.

Authors:  Leon Adriana Souza-Barbosa; S Lvia E Ferreira-Melo; Samira Ubaid-Girioli; Eduardo Arantes Nogueira; Juan Carlos Yugar-Toledo; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

7.  Carotid intima-media thickness is associated with cognitive deficiency in hypertensive patients with elevated central systolic blood pressure.

Authors:  Eros da Mota Dias; Luiz Tadeu Giollo; Débora Dada Martinelli; Camila Mazeti; Heitor Moreno Júnior; José Fernando Vilela-Martin; Juan Carlos Yugar-Toledo
Journal:  Cardiovasc Ultrasound       Date:  2012-10-18       Impact factor: 2.062

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.